Innovation Pharmaceuticals Inc (IPIX)

[Hugon]

There are countless stories of drugs thrown into the trash bins repurposed by big pharma into blockbuster drugs. A drug may fail in one indication, be chucked into the garbage, and then be brought to life by another company and turned into a billion dollar plus gem. Happens more than you think. The thing is Brilacidin wasn’t junk. It completed a phase 2B with solid results inferior to a blockbuster drug in absssi dapto (you have heard of it or taken it). The antibiotic market (then was trash) and now the world is changing. And ipix has expanded the drug into a platform that keeps working. No failed trials.